Akèy › Maladi Crohn › Florid › Orlando
Etid klinik pou Maladi Crohn nan Orlando, FL
17 etid pou Maladi Crohn ap chèche patisipan nan sit nan ak bò kote Orlando (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
Ap rekriteFaz 4
- Endoscopic Research, Inc., Orlando
- Orlando Health-Orlando Regional Medical Center, Orlando
- Digestive and Liver Center of Florida, P.A., Kissimmee · 16 mi lwen
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Ap rekriteFaz 3
- AdventHealth Orlando ( Site 5131), Orlando
- Endoscopic Research Inc ( Site 5061), Orlando
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
Ap rekriteFaz 2
- Digestive And Liver Center Of Florida - Orlando /ID# 280924, Orlando
- Clinical Research of Osceola /ID# 280593, Kissimmee · 16 mi lwen
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
Ap rekriteFaz 2
- AdventHealth (Florida Hospital) Medical Group, Orlando
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
Ap rekriteFaz 2
- Endoscopic Research, Inc. /ID# 267211, Orlando
- Novum Research /ID# 278128, Clermont · 24 mi lwen
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Ap rekriteFaz 3
- Orlando Health, Orlando
- Digestive and Liver Center of Florida, Orlando
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Ap rekriteFaz 3
- AdventHealth Orlando-Site Number: 8400070, Orlando
- Orlando Health, Inc.-Site Number: 8400084, Orlando
- Clinical Research of Osceola-Site Number: 8400013, Kissimmee · 16 mi lwen
- ak 1 plis
A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease
Ap rekriteFaz 3
- Arnold Palmer Hospital for Children Center Digestive Health and Nutrition-Orland /ID# 255437, Orlando
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Ap rekriteFaz 3
- Orlando Health, Inc., Digestive Health Institute-Site Number: 8400084, Orlando
- Clinical Research of Osceola-Site Number: 8400013, Kissimmee · 16 mi lwen
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
Ap rekriteFaz 2
- Endoscopic Research Inc, Orlando
- Clinical Research of Osceola, Kissimmee · 16 mi lwen
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
Ap rekriteFaz 4
- Endoscopic Research Inc, Orlando
- Clinical Research of Osceola, Kissimmee · 16 mi lwen
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
Ap rekrite
- Advent Health, Orlando
Zymfentra (Infliximab-dyyb) REal World Cohort STudy
Ap rekriteEtid obsèvasyon
- AdventHealth, Orlando
Open-label Single-arm Study to Assess the Efficacy of Mirikizumab in Patients With Inflammatory Strictures Due to CD
Ap rekriteFaz 4
- Digestive & Liver Center of Florida, Orlando
Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
Ap rekriteFaz 2
- Orlando Health, Inc., Orlando
A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease
Ap rekriteFaz 2
- Investigational Site Number: 8400007, Orlando
- Investigational Site Number: 8400017, Kissimmee · 16 mi lwen
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
Ap rekriteFaz 2
- Mirador Therapeutics Selected Site, Orlando
Etid Maladi Crohn nan lòt vil
- New York City, NY35 etid
- Miami, FL19 etid
- Boston, MA19 etid
- St. Louis, MO19 etid
- Cleveland, OH18 etid
- Houston, TX17 etid
- Atlanta, GA17 etid
- Tyler, TX16 etid
- Los Angeles, CA15 etid
- San Antonio, TX15 etid
- San Diego, CA15 etid
- Colorado Springs, CO13 etid
Lòt etid nan Orlando
- Kansè Poumon ki pa ti selil44 etid
- Kansè Metastatik29 etid
- Obèsite29 etid
- Kansè (tout kalite)25 etid
- Maladi Alzheimer25 etid
- Sipwa25 etid
- Dyabèt Tip 224 etid
- Kansè nan tete23 etid
- Kolit Ulseratif23 etid
- Kansè ovè22 etid
- Kansè poumon21 etid
- Kansè kolorektal19 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.